Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Human Immunodeficiency Virus-Type 1”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT02367807
What this trial is testing

PrEP With TDF/FTC to Prevent HIV-1 Acquisition in Young MSM and Transgender Women of Color

Who this might be right for
HIV
Philadelphia Fight 50
Not applicableApproved For MarketingNCT00097799
What this trial is testing

Tipranavir Expanded Access Program (EAP) in PI-experienced Patients With HIV-1 Infection

Who this might be right for
HIV Infections
Boehringer Ingelheim
Early research (Phase 1)Study completedNCT00984971
What this trial is testing

Rectal Microbicide Safety and Acceptability Trial of Topically Applied Tenofovir Compared With Oral Tablet

Who this might be right for
HIV PreventionHIV Infections
CONRAD 18
Early research (Phase 1)Study completedNCT01127464
What this trial is testing

DCVax Plus Poly ICLC in Healthy Volunteers

Who this might be right for
HIV-1 InfectionHIV InfectionHealthy Volunteers
Rockefeller University 43
Large-scale testing (Phase 3)Study completedNCT00002193
What this trial is testing

Safety and Effectiveness of Giving Two Nucleoside Reverse Transcriptase Inhibitors Alone or in Combination With 141W94 to HIV-Infected Children Who Have Never Received Protease Inhibitors

Who this might be right for
HIV Infections
Glaxo Wellcome 210
Testing effectiveness (Phase 2)Study completedNCT00002221
What this trial is testing

Gene Therapy in HIV-Positive Patients With Non-Hodgkin's Lymphoma

Who this might be right for
Lymphoma, Non-HodgkinHIV Infections
Ribozyome 5
Large-scale testing (Phase 3)Study completedNCT01815736
What this trial is testing

Study to Evaluate Switching From a TDF-Containing Combination Regimen to a TAF-Containing Fixed Dose Combination (FDC) in Virologically-Suppressed, HIV-1 Positive Participants

Who this might be right for
HIVHIV Infections
Gilead Sciences 1,443
Not applicableStudy completedNCT02363387
What this trial is testing

Suppression of HIV 1 RNA in People Living With HIV

Who this might be right for
HIV
Johns Hopkins University 102
Not applicableStudy completedNCT00884793
What this trial is testing

Pilot Study on the Effect of Adding Raltegravir +/- a Second Drug on HIV Levels in the Gut

Who this might be right for
HIV Infections
University of California, San Francisco 8
Post-approval studies (Phase 4)Study completedNCT01533272
What this trial is testing

Study Comparing Two Alternatives of Antiretroviral Therapy as Post-exposure Prophylaxis to HIV-1:FOVIR+EMTRICITABINA + LOPINAVIR/RITONAVIR VS TENOFOVIR+EMTRICITABINA + MARAVIROC (MARAVI-PEP)

Who this might be right for
HIV Infection
Hospital Clinic of Barcelona 240
Testing effectiveness (Phase 2)Study completedNCT00967187
What this trial is testing

Safety and Efficacy Study of MPC-4326 for Treatment of Patients With HIV-1 Infection.

Who this might be right for
HIV Infections
Myrexis Inc. 32
Large-scale testing (Phase 3)Study completedNCT02733419
What this trial is testing

Efficacy, and Safety Study of Optimized Background Antiretroviral Regimen (OB) in Combination With Enfuvirtide in the Treatment-Experienced Participants With Human Immunodeficiency Virus-1 (HIV-1) Infection

Who this might be right for
HIV Infections
Hoffmann-La Roche 84
Not applicableStudy completedNCT01024764
What this trial is testing

Observational Study of the Preventive Trial With HIV-1 Tat Protein

Who this might be right for
Healthy Subjects
Istituto Superiore di Sanità 5
Testing effectiveness (Phase 2)Study completedNCT00158509
What this trial is testing

Randomised Controlled Trial Assessing the Impact of Genital Herpes Suppressive Therapy on HIV Shedding

Who this might be right for
Herpes GenitalisHIV Infection
French National Agency for Research on AIDS and Viral Hepatitis 215
Not applicableStudy completedNCT00112593
What this trial is testing

Fludarabine and Total-Body Irradiation Followed By Donor Stem Cell Transplant and Cyclosporine and Mycophenolate Mofetil in Treating HIV-Positive Patients With or Without Cancer

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaAcute Undifferentiated LeukemiaAdult Acute Lymphoblastic Leukemia in Remission+176 more
Fred Hutchinson Cancer Center 5
Large-scale testing (Phase 3)Looking for participantsNCT06507059
What this trial is testing

Outcomes of the PLHIV With Suboptimal Viral Suppression to Injectable Long-acting Antiretrovirals

Who this might be right for
HIV-1-infectionNon-Adherence, Medication
Chang Gung Memorial Hospital 40
Early research (Phase 1)Study completedNCT02028403
What this trial is testing

Safety and Immune Response of BMS-936559 in HIV-Infected People Taking Combination Antiretroviral Therapy

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 8
Not applicableLooking for participantsNCT05985642
What this trial is testing

Observational PIC Destination Cohort

Who this might be right for
HIV-1-infection
Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections 30
Not applicableWithdrawnNCT00023218
What this trial is testing

Effect of a Change in HIV Therapy on Liver Steatosis, Inflammation, and Fibrosis

Who this might be right for
HIV InfectionsHepatitis C
National Institute of Allergy and Infectious Diseases (NIAID)
Testing effectiveness (Phase 2)Ended earlyNCT01737359
What this trial is testing

A Safety and Efficacy Study of Amdoxovir in HIV-1 Treatment-experienced Subjects.

Who this might be right for
Human Immunodeficiency Virus Infection
RFS Pharma, LLC 2
Next Page